Gts Securities LLC Novartis Ag Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$106.13 - $120.89 $5.08 Million - $5.79 Million	47,900 Added 142.56%	81,500 $9.37 Million
Q2 2024 Aug 14, 2024	SELL	$92.57 - $107.37 $212,910 - $246,951	-2,300 Reduced 6.41%	33,600 $3.58 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $4.27 Million - $4.86 Million	-44,800 Reduced 55.51%	35,900 $3.47 Million
Q4 2023 Feb 14, 2024	SELL	$92.27 - $101.54 $1.27 Million - $1.4 Million	-13,800 Reduced 14.6%	80,700 $8.15 Million
Q3 2023 Nov 15, 2023	BUY	$94.73 - $105.13 $8.95 Million - $9.93 Million	94,500 New	94,500 $9.63 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $208B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.